CRP CP3826Recalls & reported problems
Randox Laboratories Limited · The CRP test system is intended for the quantitative in vitro determination of CRP concentration in serum. · Class 2
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 0
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
No MAUDE adverse event reports in our data reference this device identifier directly.
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Recalls naming this device
- Feb 1, 2023Open, Classified
The Antibody (R2 reagent) is showing a positive bias compared to previous batches on patient samples. Quality Controls do not show the same bias and will be within range
Z-1286-2023 · Root cause: Under Investigation by firm · FDA record ↗
Other C-Reactive Protein, Antigen, Antiserum, And Control devices
- VITROS 8097990Ortho-Clinical Diagnostics, Inc. · C-REACTIVE PROTEIN, ANTIGEN, ANTISERUM, AND CONTROL1 recall1 report
- VITROS 1926740Ortho-Clinical Diagnostics, Inc. · C-REACTIVE PROTEIN, ANTIGEN, ANTISERUM, AND CONTROL1 recall0 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.